A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
Clinical trial NCT02549196 · COMPLETED
Trial details
- NCT number
- NCT02549196
- Sponsor
- Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-07
- Primary completion
- 2017-09-28
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.